External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer.

MLA

Wei, Lijuan, et al. “External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer.” Frontiers in Oncology, vol. 12, May 2022, pp. 1–8. EBSCOhost, https://doi.org/10.3389/fonc.2022.873367.

APA

Wei, L., Hou, Q., Liu, J., Yao, N., Liang, Y., Cao, X., Sun, B., Li, H., Xu, S., & Cao, J. (2022). External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer. Frontiers in Oncology, 12, 1–8. https://doi.org/10.3389/fonc.2022.873367

Chicago

Wei, Lijuan, Qing Hou, Jianting Liu, Ningning Yao, Yu Liang, Xin Cao, Bochen Sun, Hongwei Li, Shuming Xu, and Jianzhong Cao. 2022. “External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer.” Frontiers in Oncology 12 (May): 1–8. doi:10.3389/fonc.2022.873367.